These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7530646)

  • 21. Thyrotropin (TSH) receptor autoantibodies do not appear to bind to the TSH receptor produced in an in vitro transcription/translation system.
    Prentice L; Sanders JF; Perez M; Kato R; Sawicka J; Oda Y; Jaskolski D; Furmaniak J; Smith BR
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1288-92. PubMed ID: 9100609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroperoxidase, but not the thyrotropin receptor, contains sequential epitopes recognized by autoantibodies in recombinant peptides expressed in the pUEX vector.
    Libert F; Ludgate M; Dinsart C; Vassart G
    J Clin Endocrinol Metab; 1991 Oct; 73(4):857-60. PubMed ID: 1716261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the peptides that inhibit the stimulation of thyrotropin receptor by Graves' immunoglobulin G from peptide libraries.
    Park JY; Kim IJ; Lee MH; Seo JK; Suh PG; Cho BY; Ryu SH; Chae CB
    Endocrinology; 1997 Feb; 138(2):617-26. PubMed ID: 9002995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
    Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
    Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of recombinant human thyrotropin receptors versus porcine thyrotropin receptors in the thyrotropin binding inhibition assay for thyrotropin receptor autoantibodies.
    Kakinuma A; Morimoto I; Kuroda T; Fujihira T; Eto S; McLachlan SM; Rapoport B
    Thyroid; 1999 Sep; 9(9):849-55. PubMed ID: 10524562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mouse monoclonal antibody to the TSHR.
    Stankowiak-Kulpa H; Sanders J; Depraetere H; Jeffreys J; Evans M; Richards T; Furmaniak J; Smith BR
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):345-51. PubMed ID: 16088319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
    Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
    Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical Differences between Induced and Spontaneous Mouse Models of Graves' Disease with Implications for Antigen-Specific Immunotherapy in Humans.
    Rapoport B; Banuelos B; Aliesky HA; Hartwig Trier N; McLachlan SM
    J Immunol; 2016 Dec; 197(12):4560-4568. PubMed ID: 27913646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of a human thyrotrophin receptor fragment in Escherichia coli and its interaction with the hormone and autoantibodies from patients with Graves' disease.
    Huang GC; Collison KS; McGregor AM; Banga JP
    J Mol Endocrinol; 1992 Apr; 8(2):137-44. PubMed ID: 1515018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of a unique region of the human thyrotropin receptor.
    Nagy EV; Burch HB; Lukes YG; Carr FE; Kosugi S; Kohn LD; Burman KD
    J Endocrinol Invest; 1993; 16(7):485-93. PubMed ID: 7901266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the murine immune response to the murine TSH receptor ectodomain: induction of hypothyroidism and TSH receptor antibodies.
    Vlase H; Weiss M; Graves PN; Davies TF
    Clin Exp Immunol; 1998 Jul; 113(1):111-8. PubMed ID: 9697993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TSH receptor sequences recognized by CD4+ T cells in Graves' disease patients and healthy controls.
    Kellermann SA; McCormick DJ; Freeman SL; Morris JC; Conti-Fine BM
    J Autoimmun; 1995 Oct; 8(5):685-98. PubMed ID: 8579724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticles Bearing TSH Receptor Protein and a Tolerogenic Molecule Do Not Induce Immune Tolerance but Exacerbate Thyroid Autoimmunity in hTSHR/NOD.
    McLachlan SM; Aliesky HA; Rapoport B
    J Immunol; 2019 May; 202(9):2570-2577. PubMed ID: 30944161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
    Kung AW; Lau KS; Kohn LD
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limitations of the semisynthetic library approach for obtaining human monoclonal autoantibodies to the thyrotropin receptor of Graves' disease.
    Van Der Heijden JH; De Bruin TW; Glaudemans KA; De Kruif J; Banga JP; Logtenberg T
    Clin Exp Immunol; 1999 Nov; 118(2):205-12. PubMed ID: 10540180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-reactivity of a monoclonal antibody to the amino terminal region of thyrotropin receptor with the serum protein alpha(1)-antitrypsin.
    Piotrowska U; Adler G; Gardas A; Gietka-Czernel M; Kaniewski M; Banga JP
    Thyroid; 2002 Jul; 12(7):563-70. PubMed ID: 12193299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain.
    Soliman M; Kaplan E; Yanagawa T; Hidaka Y; Fisfalen ME; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Mar; 80(3):905-14. PubMed ID: 7533773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of the first extracellular loop of thyrotropin receptor prevents ligand binding.
    Haraguchi K; Saito T; Endo T; Onaya T
    Life Sci; 1994; 55(12):961-8. PubMed ID: 7914657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.